These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 19216803)

  • 1. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.
    Kim J; Hong SJ; Lim EK; Yu YS; Kim SW; Roh JH; Do IG; Joh JW; Kim DS
    J Exp Clin Cancer Res; 2009 Feb; 28(1):20. PubMed ID: 19216803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated N-methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform.
    Li J; You S; Zhang S; Hu Q; Wang F; Chi X; Zhao W; Xie C; Zhang C; Yu Y; Liu J; Zhao Y; Liu P; Zhang Y; Wei X; Li Q; Wang X; Yin Z
    Mol Oncol; 2019 Sep; 13(9):1993-2009. PubMed ID: 31294922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma.
    Win KT; Lee SW; Huang HY; Lin LC; Lin CY; Hsing CH; Chen LT; Li CF
    Tumour Biol; 2013 Dec; 34(6):3923-31. PubMed ID: 23838801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
    Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
    World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer.
    Li J; Yue H; Yu H; Lu X; Xue X
    BMC Cancer; 2021 Jan; 21(1):67. PubMed ID: 33446144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
    Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J
    Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of nicotinamide N-methytransferase overexpression on biological behaviors of SMMC7721 hepatocellar carcinoma cell line].
    Mu X; Chen Y; Wang SH; Li M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 44(2):193-5, 217. PubMed ID: 23745253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells.
    Tomida M; Ohtake H; Yokota T; Kobayashi Y; Kurosumi M
    J Cancer Res Clin Oncol; 2008 May; 134(5):551-9. PubMed ID: 17922140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cystathionine beta-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis.
    Kim J; Hong SJ; Park JH; Park SY; Kim SW; Cho EY; Do IG; Joh JW; Kim DS
    Oncol Rep; 2009 Jun; 21(6):1449-54. PubMed ID: 19424622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma.
    Sartini D; Santarelli A; Rossi V; Goteri G; Rubini C; Ciavarella D; Lo Muzio L; Emanuelli M
    Mol Med; 2007; 13(7-8):415-21. PubMed ID: 17622326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
    Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
    World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer.
    Ogawa M; Tanaka A; Namba K; Shia J; Wang JY; Roehrl MHA
    Sci Rep; 2022 Feb; 12(1):2767. PubMed ID: 35177765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: potential for the development of a urine-based diagnostic test.
    Sartini D; Muzzonigro G; Milanese G; Pozzi V; Vici A; Morganti S; Rossi V; Mazzucchelli R; Montironi R; Emanuelli M
    Cell Biochem Biophys; 2013 Apr; 65(3):473-83. PubMed ID: 23097023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.
    Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç
    J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
    Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
    Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma.
    Ganzetti G; Sartini D; Campanati A; Rubini C; Molinelli E; Brisigotti V; Cecati M; Pozzi V; Campagna R; Offidani A; Emanuelli M
    Melanoma Res; 2018 Apr; 28(2):82-88. PubMed ID: 29420365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile and prognostic value of NNMT in patients with pancreatic cancer.
    Xu Y; Liu P; Zheng DH; Wu N; Zhu L; Xing C; Zhu J
    Oncotarget; 2016 Apr; 7(15):19975-81. PubMed ID: 26942567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEP domain containing 1 is a novel diagnostic marker and prognostic predictor for hepatocellular carcinoma.
    Yuan SG; Liao WJ; Yang JJ; Huang GJ; Huang ZQ
    Asian Pac J Cancer Prev; 2014; 15(24):10917-22. PubMed ID: 25605201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma.
    Huang SF; Wu HD; Chen YT; Murthy SR; Chiu YT; Chang Y; Chang IC; Yang X; Loh YP
    Tumour Biol; 2016 Jul; 37(7):9745-53. PubMed ID: 26803519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.